Glycemic control in mice with targeted disruption of the glucagon receptor gene

Biochemical and Biophysical Research Communications

Volumn 290, Issue 2, 2002, Pages 839-843

  Parker, Janice C ^a   Andrews, Kim M ^a   Allen, Melanie R ^a   Stock, Jeffrey L ^a   McNeish, John D ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Glucagon; Glucagon receptor; Glucose tolerance; Glycemia; Pancreas; cell

Indexed keywords

CHOLESTEROL; GLUCAGON; GLUCAGON RECEPTOR; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; EMBRYO; FEEDING; GENE DISRUPTION; GENE INACTIVATION; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA;

EID: 0036296165     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.6265     Document Type: Article

References (17)

1. Expression cloning and signaling properties of the rat glucagon receptor
2. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver
3. Activation of two signal transduction systems in hepatocytes by glucagon
4. 9]glucagon amide, a glucagon antagonist
5. Sensitivity of the response of cytosolic calcium in Quin-2-loaded rat hepatocytes to glucagon, adenine nucleosides, and adenine nucleotides
6. Glucagon: Role in the hyperglycemia of diabetes mellitus
7. The essential role of glucagon in the pathogenesis of diabetes mellitus
8. Role of hyperglucagonemia in the maintenance of increased rates of hepatic glucose output in Type 2 diabetics
9. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus
10. Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist
11. Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes
12. A new embryonic stem cell line from DBA/1lacJ mice allows genetic modification in a murine model of human inflammation
13. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes
14. Identification of a glucagon receptor gene deletion mutation in a patient with hyperglucagonemia and pseudoadenomatous hyperplasia of pancreatic alpha-cells
15. Effect of glucagon on blood cholesterol levels in rats
16. Further studies concerning glucagon-induced hypocholesterolemia
17. The effects of a specific glucagon antagonist on glucagon stimulated glucose production